Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1992 2
1993 12
1994 3
1995 2
1996 10
1997 25
1998 26
1999 17
2000 10
2001 25
2002 33
2003 35
2004 50
2005 53
2006 54
2007 66
2008 75
2009 89
2010 79
2011 85
2012 107
2013 109
2014 154
2015 311
2016 424
2017 449
2018 556
2019 578
2020 691
2021 761
2022 764
2023 771
2024 330

Text availability

Article attribute

Article type

Publication date

Search Results

5,818 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Nicholson
Page 1
Fiona Marshall.
[No authors listed] [No authors listed] Nat Rev Drug Discov. 2018 Feb 28;17(3):158-159. doi: 10.1038/nrd.2018.25. Nat Rev Drug Discov. 2018. PMID: 29487388 No abstract available.
Fiona Watt.
Watt F. Watt F. Curr Biol. 2003 Apr 29;13(9):R342. doi: 10.1016/s0960-9822(03)00267-7. Curr Biol. 2003. PMID: 12725743 Free article. No abstract available.
Fiona.
Moreno MA. Moreno MA. Arch Pediatr Adolesc Med. 2006 Jan;160(1):15-6. doi: 10.1001/archpedi.160.1.15. Arch Pediatr Adolesc Med. 2006. PMID: 16389205 No abstract available.
The next big epidemic? Device shutdowns.
Ecarnot F, Mouhat B, Giffard M, Pillet M, Seronde MF. Ecarnot F, et al. Intensive Care Med. 2022 Feb;48(2):238-239. doi: 10.1007/s00134-021-06584-y. Epub 2022 Jan 14. Intensive Care Med. 2022. PMID: 35028682 No abstract available.
Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model.
Piepho AB, Lowe J, Cumby LR, Dorn LE, Lake DM, Rastogi N, Gertzen MD, Sturgill SL, Odom GL, Ziolo MT, Accornero F, Chamberlain JS, Rafael-Fortney JA. Piepho AB, et al. Mol Ther Methods Clin Dev. 2023 Feb 9;28:344-354. doi: 10.1016/j.omtm.2023.02.001. eCollection 2023 Mar 9. Mol Ther Methods Clin Dev. 2023. PMID: 36874243 Free PMC article.
Collagen in cardiac fibrotic scars becomes more tightly packed from 12 to 18 months in Fiona/dko mice, but the area of fibrosis containing tenascin C does not change. Increased tight collagen correlates with unexpected improvements in Fiona/dko whole-heart function …
Collagen in cardiac fibrotic scars becomes more tightly packed from 12 to 18 months in Fiona/dko mice, but the area of fibrosis conta …
Lipids and cardiovascular disease.
Burnett JR, Hooper AJ, Hegele RA. Burnett JR, et al. Pathology. 2019 Feb;51(2):129-130. doi: 10.1016/j.pathol.2018.12.001. Epub 2018 Dec 27. Pathology. 2019. PMID: 30595506 No abstract available.
Fluorescence imaging with one-nanometer accuracy (FIONA).
Wang Y, Cai E, Sheung J, Lee SH, Teng KW, Selvin PR. Wang Y, et al. J Vis Exp. 2014 Sep 26;(91):51774. doi: 10.3791/51774. J Vis Exp. 2014. PMID: 25286081 Free PMC article.
Here a summary of the FIONA technique is reported and examples of research that have been performed using FIONA are briefly described. ...Then how to carry out a simple FIONA experiment on localizing immobilized Cy3-DNA single molecules using appropriate prot …
Here a summary of the FIONA technique is reported and examples of research that have been performed using FIONA are briefly de …
Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.
Schaefer F, Montini G, Kang HG, Walle JV, Zaritsky J, Schreuder MF, Litwin M, Scalise A, Scott H, Potts J, Iveli P, Breitenstein S, Warady BA. Schaefer F, et al. Trials. 2024 Mar 21;25(1):203. doi: 10.1186/s13063-024-08021-z. Trials. 2024. PMID: 38509517 Free PMC article. Clinical Trial.
The primary objective of FIONA OLE is to provide long-term safety data. FIONA has two primary endpoints: urinary protein-to-creatinine ratio (UPCR) reduction of 30% from baseline to day 180 and percent change in UPCR from baseline to day 180. ...CONCLUSION: FIONA …
The primary objective of FIONA OLE is to provide long-term safety data. FIONA has two primary endpoints: urinary protein-to-cr …
5,818 results